The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000001100
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Ovid Technologies (Wolters Kluwer Health)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy